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Abstract
Background: In a cohort of children in Cyprus, we recently reported low levels of high density lipoprotein cholesterol
(HDL-C) to be associated with asthma. We examined whether genetic polymorphisms that were previously linked
individually to asthma, obesity, or HDL-C are associated with both asthma and HDL-C levels in the Cyprus cohort.
Methods: We assessed genotypes frequencies in current-wheezers (n = 190) and non-asthmatic controls (n = 671) and
HDL-C levels across several genotypes. Binary logistic regression models were used to assess the effect of genotypes
on wheezing risk and examined whether this effect is carried out through changes of HDL–C.
Results: Of the 16 polymorphisms tested, two polymorphisms TNFa rs3093664 and PRKCA rs9892651 presented
significant differences in genotype distribution among current-wheezers and controls. Higher HDL-C levels were
noted in carriers of genotype GG of polymorphism TNFa rs3093664 that was protective for wheezing Vs AG and
AA genotypes (65.3 Vs 51.8 and 53.3 mg/dl, p-value < 0.001 and p-value for trend = 0.028). In polymorphism PRKCA
rs9892651, HDL-C levels were lower in carriers of CC and TC genotypes that were more frequent in current-wheezers
Vs TT genotype (52.2 and 52.7 Vs 55.2 mg/dl, p-value = 0.042 and p-value for trend = 0.02). The association of TNFa
rs3093664 with wheezing is partly mediated by its effect on HDL-C whereas association of PRKCA rs9892651 with
wheezing appeared to be independent of HDL-C.
Conclusions: We found evidence that two SNPs located in different genetic loci, are associated with both wheezing
and HDL-C levels, although more studies in other populations are needed to confirm our results.
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Background
High density lipoprotein cholesterol (HDL-C) is widely
known to have systemic and vascular anti-inflammatory
properties [1] and, as shown in vitro, also anti-
inflammatory effects consistent with a protective role in
asthma [2]. In a cohort of 3982 children in Cyprus, we
recently reported low levels of HDL-C at age 11–12 years
to be associated with active asthma five years later in
adolescence, suggesting a potential role of this lipopro-
tein in the pathogenesis of pediatric asthma [3]. Obesity
is also widely accepted to be related to asthma [4] as
well as with low serum HDL-C levels [5] and conse-
quently it may play a confounding or mediating role in
the asthma – HDL-C association.
Numerous individual studies confirmed the implication
of genetic factors in the development of asthma [6], obesity
[7] or low HDL-C [8]. In addition, epidemiological studies
in twins have suggested that the association of asthma and
allergy with obesity or low HDL-C levels could, at least in
part, be explained by the presence of shared genetic factors
[9]. In the case of asthma and obesity, overlapping
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genomic regions for common susceptibility genes on chro-
mosomes 5, 6, 11 and 12 have been identified by linkage
analysis studies [10]. Specifically, some of the most known
candidate genes and genetic loci for asthma and allergy [6,
11] have already been linked [12] to the pathogenesis of
obesity such as the tumor necrosis factor alpha (TNF-a)
gene [12], the protein kinase C alpha (PRKCA) gene [13]
and β2‐adrenergic receptor (ADRB2) [14]. To date how-
ever, no common genetic loci were reported to be associ-
ated with asthma and HDL-C levels.
In this study, we selected 16 single nucleotide polymor-
phisms (SNPs) located in genes that were linked to asthma
and/or obesity or HDL-C and examined in the Cyprus co-
hort of children a) whether they were associated with both
asthma and HDL-C levels and b) explored, in the SNPs
that were associated with both conditions, whether the as-




The participants of this study were selected from a co-
hort of 3982 children who participated in two large
school-based health surveys in Cyprus (Fig. 1). The first
survey spanned years 2001–2003 and involved all chil-
dren (n = 19,849) attending the 6th grade from all pri-
mary schools across Cyprus and focused on nutrition
and physical fitness. The second survey was conducted
in year 2007, followed-up 3982 of the subjects who took
part in the first survey (20.1 %) and focused on respira-
tory health (International Study of Asthma and Allergies
in Childhood – ISAAC) and risk factors for asthma. In a
case-control design, we invited all those from the 3982
children who on the second survey (ISAAC question-
naire) reported wheezing in the past 12 months (n =
297) to participate in this study along with a triplicate
number of healthy controls (n = 932).
Fig. 1 Course of the study: From the 19,849 participants (11–12 years) in Survey 1, a random sample of 3982 adolescents (15–17 years) participated in
Survey 2. All (n = 297) subjects from the 3982 sample, who reported wheezing in the last 12 months were invited to participate as cases. A sample of
932 children with no diagnosis of asthma and no wheezing in the past 12 months were invited to participate as controls
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Phenotype description
Current wheezers (CUWH) were named those who re-
ported wheezing in the past 12 months. For the purpose
of performing a sensitivity analysis, the case definition
was further refined to Active Asthma (ACAS), if also
there was report of diagnosis of asthma ever. Controls
were selected amongst the 3982 adolescents who did not
report any wheezing or asthma ever (Never Wheezers
Never Asthmatics - NWNA). NWNA were selected
using a stratified random sampling approach in order to
increase the probability of selection of children at the
extremes of Body Mass Index (BMI) change between
childhood and adolescence, in line with the scope of an-
other study on the relation of adiposity and serum lipids
with asthma [15]. The full scale of BMI change (and
BMI) was represented in the final sample, just in slightly
different proportions compared to the general popula-
tion i.e. there was slight over-representation of partici-
pants whose BMI increased or decreased between
childhood and adolescence and, equivalently slight
under-representation of children whose BMI remained
stable over this period. In all analyses normalized sam-
pling weights based on inverse probability of selection
from the original population were used.
In the asthmatic groups, information was also obtained
regarding the presence of exercise induced wheezing and
admissions ever in hospital for an asthma attack. IgE
sensitization was assessed with skin prick tests (SPT) to 8
common aeroallergens (Greer, USA), performed and inter-
preted according to the GA2LEN recommendations [16].
Children with a positive SPT to any of the 8 allergens
tested were considered sensitized to IgE. Asthmatic
children had measurements of forced expiratory volume
in one second (FEV1) (Vitallograph, UK) and values were
expressed as percent of predicted [17].
The adolescents had anthropometric measurements
and assessments of serum total cholesterol (TC), low
density lipoprotein cholesterol (LDL-C), HDL-C and
triglycerides (TG) after a 12-h fast. We calculated BMI
(kg/m2) and expressed it as age- and gender-specific
z-scores based on the United States’ Centers for Dis-
ease Control 2000 growth charts [18]. Lipids were de-
termined with the ILab 600 analyzer using ILab
Chemistry systems (Instrumentation Laboratory SpA,
Monza, Milano, Italy). The assays’ coefficients of vari-
ation were 2.08 % for TC, 1.53 % for HDL-C, 1.15 %
for LDL-C and 2.45 % for TG.
SNPs selection, DNA extraction and genotyping
Using the NCBI PubMed Entrez database, a total of 16
SNPs in ten genes that were previously reported [12–14,
19–30] to be associated individually with asthma, obesity
or HDL-C were selected for genotyping (Table 1).
Venous blood specimens were collected from partici-
pants in EDTA treated tubes that were transported on
ice to the laboratory. DNA was extracted from periph-
eral blood lymphocytes using the standard phenol ex-
traction method, and stored at −70 °C until genotyping.
Genotyping was carried out using TaqMan Real-time
PCR assay. Thirty ng of genomic DNA was used for
each reaction and the end-point PCR was carried out on
the ABI primer 7900 HT (Applied Biosystems, Foster
City, CA).
Table 1 The 16 investigated SNPs with reported links with asthma, obesity, or HDL-C
Gene Chromosome SNPs genotyped dbSNPrs# Alleles Published literature reference
IL1R1 2 1 rs1420101 C > T Gudbjartsson 2009 [19]
ACP1 2 1 rs12714402 G > A Bottini 2007 [20]
GNPDA2 4 1 rs10938397 A > G Melen 2010 [21]
IL13 5 1 rs20541 C > T Cui 2012 [22]
ADRB2 5 3 rs1800888 C > T Hall 2006 [23]
rs1042714 C > G Park 2008 [24]
rs1042713 G > A Garenc 2002 [25]
TNF-a 6 3 rs3093664 A > G Joubert 2011 [26]
rs1800629 G > A Thomas 2001 [27]
rs361525 G > A Castro 2009; Joffe 2012 [12, 28]
LEP 7 1 rs2167270 G > A Ichihara 2008 [29]
ACE 17 2 rs4343 A > G Rankinen 2006 [14]
rs4311 C > T
GSDMB 17 1 rs7216389 T > C Halapi 2010 [30]
PRKCA 17 2 rs9892651 T > C Murphy 2009 [13]
rs9901804 G > A
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Statistical analysis
Differences in participant characteristics between study-
groups were investigated in a pairwise manner (NWNA
versus CUWH and NWNA versus ACAS) using chi
square test in the case of categorical variables and t-test
in the case of continuous variables. Furthermore, chi-
squared testing was used for Hardy-Weinberg (HW)
equilibrium determination and for the investigation of
genotypes and allele frequencies associations with study
groups. Mean HDL-C levels were compared across ge-
notypes using the one-way ANOVA test and p values
and p values for trend were reported. For SNPs that pre-
sented significant effects, two binary logistic regression
models were used a) to assess the effect of genotypes on
asthma risk and b) examine whether this effect is carried
out through the change of HDL–C, after adjusting for
age and sex (Model 1), age, sex and BMI (Model 2) and
age, sex, BMI and HDL-C levels (Model 3). The geno-
type with the most protective effect for asthma was
chosen as the reference in all cases. Binary logistic re-
gression analysis was performed only among NWNA
and CUWH as the ACAS group was very small and for
most SNPs, at least one cell had no cases. Analysis was
performed with SPSS statistical package, version 20.0
(IBM, SPSS Inc., Chicago, IL).
Results
A total of 190 subjects with CUWH (of whom 69
ACAS) and 671 NWNA participated in the study. This
corresponds to 64 and 72 % response rates respectively
of the targeted population for recruitment (Fig. 1). Par-
ticipants were aged 17 years (SD 0.6) and the three
groups did not differ significantly in terms of age, gender
and BMI (Table 2). Mean HDL-C levels in the ACAS
and CUWH were significantly lower than in the controls
(47.9 and 49.1 Vs 53.4 mg/dl; p < 0.001 for both)
(Table 2). Mean serum levels of TC, LDL-C and TG
were similar in the three groups (results not shown in
detail). The frequency of atopic sensitization was 52.0 %
in ACAS and 41.4 % in CUWH (p-value = 0.073),
whereas FEV1 was normal and not different between
them (97.6 % Vs 99.1 % of predicted; p-value = 0.332) in-
dicating that they were clinically stable. ACAS were ex-
periencing more frequently exercise induced wheezing
(83.6 % vs 67.6 %, p-value < 0.001) and lifetime hospitali-
zations for asthma attack (18.8 % vs 9.0 %, p-value =
0.003) than the CUWH (Table 2). Results of minor allele
frequencies and HW equilibrium for genotype distribu-
tion are presented in Additional file 1: Table S1.
SNPs genotype distribution in CUWH Vs NWNA and HDL-
C levels
Distribution of the genotypes of the 16 polymorphisms
in CUWH Vs NWNA and the corresponding HDL-C
levels can be found in Additional file 2: Table S2. Two
polymorphisms, TNFa rs3093664 and PRKCA rs9892651
presented statistically significant and ADRB2 rs1800888
nearly significant differences in genotype distribution
among NWNA and CUWH and are presented separately
at Table 3.
The larger differences were exhibited in the genotype
distribution of TNFa rs3093664 polymorphism, where
the rare GG genotype appeared to offer a protective ef-
fect with a frequency of 4.1 % Vs 1.1 % in NWNA and
CUWH respectively (p-value = 0.03, p-value for trend =
0.912). Significantly higher HDL-C levels were noted in
subjects with GG genotype as opposed to those in AG
and AA genotype carriers (65.3 mg/dl Vs 51.8 mg/dl and
53.3 mg/dl, p-value < 0.001 and p-value for trend =
0.028) (Table 3). The genotypes of polymorphism
PRKCA rs9892651 were also found to be differentially
distributed with the frequency of genotype CC to be
higher in CUWH (19.2 %) compared to NWNA (14.3 %)
(p-value = 0.141, p-value for trend = 0.048). HDL-C levels
Table 2 Characteristics of study population according to asthma status
NWNA (Controls) CUWH (Current Wheezers) p-valuec ACAS (Active Asthmatics) p-valued
(n = 671) (n = 190) (n = 69)
Age (yrs)a 16.95 (15.91–18.00) 17.00 (16.00–18.11) 0.309 16.91 (15.91–18.07) 0.567
Sex (% female)b 57.4 % 56.9 % 0.914 56.5 % 0.894
BMI z scoresa 0.358 ( −2.13–2.16) 0.288 ( −1.73–2.20) 0.396 0.340 ( −1.87–2.37) 0.896
HDL (mg/dl)a 53.4 (30.00–86.50) 49.1 (30.00–71.55) <0.001 47.9 (31.73–73.75) <0.001
Atopic Sensitization (% positive)b - 41.4 % - 52.0 % 0.073e
FEV1 (% predicted)a - 99.1 (72.9–130.5) - 97.6 (62.0–125.6) 0.332e
Exercise Induced Wheezing (% positive)b - 67.6 % - 83.6 % <0.001e
Hospitalization (% positive)b - 9.0 % - 18.8 % 0.003e
aMean and 95 % CI, Independent sample t test for equality of means (2-sited significance)
bPercentage, χ2 test (asymptomatic 2-sited significance)
cComparison between NWNA and CUWH
dComparison between NWNA and ACAS
eComparison between CUWH and ACAS
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were also significantly lower in subjects with the CC and
TC genotype compared to TT genotype (52.2 mg/dl and
52.7 mg/dl Vs 55.2 mg/dl, p-value = 0.042 and p-value
for trend = 0.02).
The only other SNP that displayed nearly significant dif-
ferences in genotype frequencies was ADRB2 rs1800888,
where the heterozygous genotype CT had a higher fre-
quency in NWNA compared to CUWH (5 % Vs 2.2 %, p-
value = 0.076) thus exhibiting a protective effect compared
with the homozygote CC genotype. HDL-C levels in the
protective CT genotype carriers were not significantly
higher at the 5 % level to those in CC, probably due to the
small size of the CT genotype group (57.24 mg/dl Vs
53.28 mg/dl, p-value = 0.092).
SNPs genotype distribution in ACAS Vs NWNA and HDL-C
levels
As a sensitivity analysis, the same investigations were
performed between the more strictly defined asthmatic
phenotype ACAS and NWNA. In general, the magni-
tude and direction of the relationships of the three SNPs
genotypes in ACAS and NWNA remained consistent
with the findings of the NWNA Vs CUWH analysis al-
though these were not always significant probably due to
the smaller size of the ACAS study-group. A detailed de-
scription of these findings is presented with Additional
file 3: Table S3. Allelic associations of the 16 tested SNPs
with study groups were not statistically different and are
presented in Additional file 4: Table S4.
Associations of SNPs genotypes with CUWH and the
mediating role of HDL-C levels
Associations of rs3093664, rs9892651 and rs1800888 ge-
notypes with CUWH were explored in binary logistic re-
gression models adjusted for age and sex (Model 1) age,
sex and BMI (Model 2) and with the inclusion of HDL-
C levels (Model 3) (Table 4). The estimates in all com-
parisons between Models 1 and 2 were very similar, thus
excluding any confounding or mediating effect of BMI.
In particular, for the TNF-a rs3093664 polymorphism,
the Odds Ratios (ORs) of having CUWH for genotypes
AA and AG against GG were 3.35 (95 % CI 0.78, 14.35)
and 4.92 (95 % CI 1.11, 21.8) respectively (Model 2).
After further adjusting for HDL-C (Model 3), the calcu-
lated ORs of CUWH were attenuated by approximately
40 % (OR = 2.44, 95 % CI 0.56, 10.58 for genotype AA
and OR = 3.43 95 % CI 0.76, 15.53 for genotype AG),
thus indicating that the protective effect of GG for
CUWH is mediated to an important extent through
HDL-C levels.
In the case of PRKCA rs9892651, the ORs for geno-
type CC carriers to have CUWH compared to TT
(OR = 1.63, 95 % CI 0.99, 2.69) and CT (OR = 1.26,
95 % CI 0.85, 1.85) were slightly short of significance
in Model 2. In Model 3, these estimates were only
moderately attenuated for TT (OR = 1.52, 95 % CI
0.91, 2.53) and CT (OR = 1.17, 95 % CI 0.79, 1.73).
Thus PRKCA rs9892651 association with wheezing ap-
peared to be independent of HDL-C levels.
Discussion
In this case-control study, we examined the effect of 16
genetic variants on asthma phenotypes and identified
two SNPs that were simultaneously associated with the
wheezing and HDL-C levels. Although many studies
have examined separately the relationship of genetic loci
with respiratory outcomes, only few have searched for
common genetic variants between asthma and metabolic
markers [12, 13, 21, 31]. Skaaby et al., studied loss-of-
function mutations in the filaggrin gene, which are
known to be associated with asthma and allergies and
higher vitamin D, and found higher vitamin D status to
Table 3 SNPs genotype distribution in Current Wheezers (CUWH) Vs Controls (NWNA) and HDL-C levels
SNP (genotype) NWNA (n, %) CUWH (n, %) χ2 p value p trend HDL mg/dl (mean, 95 % CI) F p value p trend
ADRB2 rs1800888
CC 609 (95 %) 175 (97.8 %) 53.3 (52.3–54.2)
CT 32 (5.0 %) 4 (2.2 %) 2.535 0.076b - 57.2 (51.7–62.8) 2.840 0.092c -
TNFa rs3093664
AA 500 (79.6) 134 (76.1) 53.3 (52.2–54.3)
AG 102 (16.2) 40 (22.7) 51.7 (49.4–54.1)
GG 26 (4.1) 2 (1.1) 7.047 0.03a 0.912 65.3 (59.2–71.4) 11.787 >0.001c 0.028
PRKCA rs9892651
TT 230 (37.0) 52 (30.2) 55.2 (53.4–56.9)
CT 302 (48,6) 87 (50.6) 52.7 (51.4–54.1)
CC 89 (14.3) 33 (19.2) 3.921 0.141a 0.048 52.2 (50.0–54.5) 3.179 0.042c 0.020
aχ2 test (asymptomatic 2- sided significance)
bFischer Exact test (exact 1-sided significance)
cComparisons of means (One way ANOVA)
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be associated with higher HDL-C levels [32], suggesting
an indirect potential genetic link between asthma and al-
lergies with high HDL-C levels. In our cohort, we have
not examined polymorphisms in the filaggrin gene, but
to the best of our knowledge, this is the only study so
far which, in the same population, assessed simultan-
eously the direct association of selected SNPs with
wheezing and HDL-C levels. Interestingly, in our study
the direction of the association of wheezing and HDL-C
levels is in the opposite direction from the one implied
in the Skaaby et al. study. More importantly, our results
provide preliminary evidence that the association of
TNFa rs3093664 with wheezing is mediated in part by
its effect on HDL-C levels.
Evidence for underlying mechanisms of action
TNF-a gene codes for a highly pro-inflammatory cyto-
kine [33] involved in many pathophysiological mecha-
nisms of asthma [34, 35]. TNF-a is also known to affect
lipid metabolism and lipid serum levels [36, 37]. Specific
polymorphisms of the TNFa gene have been reported to
affect HDL-C levels [38] and have been proposed as risk
factors towards obesity, metabolic syndrome and type 2
diabetes mellitus [39]. Our findings point towards a
novel protective effect of genotype GG of TNFa
rs3093664 against wheezing but also at the same time
suggest a strong association of this genotype with higher
levels of HDL-C. To date, only few studies have exam-
ined the association of this particular polymorphism
with asthma [26] or any metabolic condition [40]. Al-
though TNF-a serum levels were not assessed in this
study, previous reports have documented that TNF-a
serum levels are inversely associated with serum HDL-C
in the general population [41], whereas administration of
anti TNF-a agents in patients with rheumatic diseases has
been shown to result in elevated HDL-C levels [42, 43].
Coupled with these observations, our results suggest that
in this small group of carriers of the GG genotype we may
have a compromised TNF-a pro-inflammatory activity,
manifesting as significantly lower risk for wheezing. At the
same time, the direct protective effect of genotype GG for
wheezing is further enhanced by the higher HDL-C levels
that result from the reduced activity of TNF-a and its in-
flammatory properties [1].
Enzyme PKC-a has been proposed to be involved in
asthma pathogenesis [44], in adipogenesis [45] and lipid
mediated insulin resistance [46]. The potential pleio-
tropic effect of PRKCA gene on asthma and BMI was
demonstrated by different SNPs influence on asthma or
obesity [13, 21], including rs9892651. Our findings also
support a pleiotropic effect of PRKCA rs9892651 as the
minor C allele appeared to be more prevalent among
current wheezers and also associated with lower HDL-C
levels, although the effect on the risk of wheezing ap-
peared to be very modest.
Polymorphisms of ADRB2 gene have been studied ex-
tensively in asthma but also in lipolysis of the adipose
tissue [47]. We examined three of the most well studied
polymorphisms of ADRB2 gene, the common rs1042714
and rs1042713 and the rarer rs1800888 [48, 49]. Our
study provides evidence in support of a modest protect-
ive role for wheezing of T allele of the rare polymorph-
ism rs1800888 but also for a modest association with
higher HDL-C levels. This is the first study which evalu-
ated the effects of rs1800888 on HDL-C levels since pre-
vious studies mainly examined cardiovascular outcomes
with conflicting results [50–52].
Study limitations
The use of self-reported questionnaire data obtained
from a young population to define wheezing and select
cases and controls is not as accurate as the use of
Table 4 Associations of TNFa, PRKCA and ADRB2 genotypes with Current Wheezers and the mediating role of HDL-C levels
SNP (genotype) Model 1 ORa (95 % CI) p-value Model 2 ORb (95 % CI) p- value Model 3 ORc (95 % CI) p- value
ADRB2 rs1800888
CT 1.00 1.00 1.00
CC 2.18 (0.76–6.29) 0.148 2.15 (0.75–6.21) 0.156 1.98 (0.68–5.79) 0.212
TNFa rs3093664
GG 1.00 1.00 1.00
AG 5.02 (1.13–22.25) 0.034 4.92 (1.11–21.80) 0.036 3.43 (0.76–15.53) 0.110
AA 3.39 (0.79–14.49) 0.100 3.35 (0.78–14.33) 0.104 2.44 (0.56–10.58) 0.239
PRKCA rs9892651
TT 1.00 1.00 1.00
CT 1.25 (0.85–1.84) 0.255 1.26 (0.85–1.85) 0.250 1.17 (0.79–1.73) 0.448
CC 1.623 (0.98–2.68) 0.058 1.63 (0.99–2.69) 0.056 1.52 (0.91–2.53) 0.110
aModel 1 adjusted for age & sex
bModel 2 adjusted for age, sex & BMI z scores
cModel 3 adjusted for age, sex, BMI z scores & HDL-C levels
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clinical parameters. We do have clinical phenotypic fea-
tures of asthma severity in the selected cases popula-
tions, as depicted in previous studies [53], but restriction
of the analyses to those with features of asthma severity
would have reduced the numbers substantially and
weaken any possible statistical associations. We think
however that any misclassification or recall bias in defin-
ing the disease status is unlikely to have been influenced
by the genotypes of the examined polymorphisms and
thus confound the recovered associations. Furthermore,
as five SNPs deviated from HW equilibrium, a random
subset (10 %) of samples was genotyped in duplicate for
quality control and reproducibility of the genotype calls
was confirmed. Populations may deviate from Hardy-
Weinberg equilibrium due to selection pressure, struc-
tured populations, in-migration, fluctuations in small
populations, and if mutations are recent. It might be ex-
pected that selection pressure might account for at least
some disequilibrium in the disease associated SNPs
identified in this study, but other SNPs that did not as-
sociate with this particular disease also showed disequi-
librium. Even if other disease processes might account
for those, this is also a small island population that has
experienced multiple historic and recent in-migrations,
and which is also a structured population. The number
of SNPs studied was limited and although we cannot ex-
clude that other genetic loci that were not tested might
also be implicated in the association between wheezing
and HDL, this does not affect the validity of the recov-
ered associations. On the other hand, we did investigate
several genes/genotypes and although we had some a
priori evidence to support our hypotheses, the associa-
tions we found do not hold after adjusting for multiple
testing by the Bonferroni method, which underlines the
need of confirmation of our results in other popula-
tions. Finally, this study remains a genetically-focused
report without functional phenotypic data on the ana-
lyzed SNP variants and HDL-related metabolites.
Nevertheless, our novel findings call for further stud-
ies to explore the physiological mechanisms behind
these associations.
Conclusions
In conclusion, this study provides a first indication that
two SNPs located in different genetic loci, TNFa
rs3093664 and PRKCA rs9892651, are associated with
both the wheezing and HDL-C levels. The association of
TNFa rs3093664 with wheezing was mediated in part by
its effect on HDL-C levels whereas the associations of
PRKCA rs9892651 with wheezing appeared to be inde-
pendent of HDL-C levels. Further studies are needed to
confirm these findings and reveal the functional mecha-
nisms implicated in the interactions of HDL with wheez-
ing and genetic loci expression.
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